Table of Content




1. Executive Summary


2. Global Omega 3 Prescription Drug Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Omega 3 Prescription Drug Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Omega 3 Prescription Drug Market by Drug
3.3.1: Vascepa
3.3.2: Lovaza
3.3.3: Others

3.4: Global Omega 3 Prescription Drug Market by Distribution Channel
3.4.1: Hospital Pharmacy
3.4.2: Retail Pharmacy
3.4.3: Online Pharmacy

3.5: Global Omega 3 Prescription Drug Market by Application
3.5.1: Hypertriglyceridemia
3.5.2: High Cholesterol
3.5.3: Inflammatory Bowel Disease
3.5.4: Rheumatoid Arthritis
3.5.5: Mental Health Conditions
3.5.6: Neurodevelopmental Disorders
3.5.7: Others




4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Omega 3 Prescription Drug Market by Region
4.2: North American Omega 3 Prescription Drug Market
4.2.2: North American Omega 3 Prescription Drug Market by Application: Hypertriglyceridemia, High Cholesterol, Inflammatory Bowel Disease, Rheumatoid Arthritis, Mental Health Conditions, Neurodevelopmental Disorders, and Others


4.3: European Omega 3 Prescription Drug Market
4.3.1: European Omega 3 Prescription Drug Market by Drug: Vascepa, Lovaza, and Others
4.3.2: European Omega 3 Prescription Drug Market by Application: Hypertriglyceridemia, High Cholesterol, Inflammatory Bowel Disease, Rheumatoid Arthritis, Mental Health Conditions, Neurodevelopmental Disorders, and Others


4.4: APAC Omega 3 Prescription Drug Market
4.4.1: APAC Omega 3 Prescription Drug Market by Drug: Vascepa, Lovaza, and Others
4.4.2: APAC Omega 3 Prescription Drug Market by Application: Hypertriglyceridemia, High Cholesterol, Inflammatory Bowel Disease, Rheumatoid Arthritis, Mental Health Conditions, Neurodevelopmental Disorders, and Others


4.5: ROW Omega 3 Prescription Drug Market
4.5.1: ROW Omega 3 Prescription Drug Market by Drug: Vascepa, Lovaza, and Others
4.5.2: ROW Omega 3 Prescription Drug Market by Application: Hypertriglyceridemia, High Cholesterol, Inflammatory Bowel Disease, Rheumatoid Arthritis, Mental Health Conditions, Neurodevelopmental Disorders, and Others



5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Omega 3 Prescription Drug Market by Drug
6.1.2: Growth Opportunities for the Global Omega 3 Prescription Drug Market by Distribution Channel
6.1.3: Growth Opportunities for the Global Omega 3 Prescription Drug Market by Application
6.1.4: Growth Opportunities for the Global Omega 3 Prescription Drug Market by Region

6.2: Emerging Trends in the Global Omega 3 Prescription Drug Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Omega 3 Prescription Drug Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Omega 3 Prescription Drug Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Abbott
7.2: Amarin Pharmaceuticals
7.3: GSK 
7.4: Natrapharm
7.5: Viatris 
7.6: Grupo Ferrer Internacional
7.7: Camber Pharmaceuticals
7.8: Dr. Reddy’s Laboratories
7.9: Zydus
7.10: Hikma Pharmaceuticals